For example, vascular endothelial growth factor (VEGF), is known to be involved in choroidal neovascularization [54] and accordingly, VEGF-blocking compounds are emerging as highly successful treatments for exudative AMD [55–58]. This evidence concerns the gene VEGFA and age-related macular degeneration.